Surgical kit manufacturer CPT Medical stated on Thursday that it is now shipping COVID-19 testing kits that are available throughout the United States.

The company has 54,000 test kits in production for allocation to hospitals, nursing homes and physician's offices by the end of next week, and expects to release 95,000 test kits for patient testing in approximately three weeks.

Developed in the company's US FDA registered facility under CDC guidelines and produced in collaboration with Premier Medical Laboratory Services, a COLA and CLIA regulated laboratory, the bulk kits are offered for nursing homes, hospitals, laboratories, physician's offices as well as individual kits for laboratories. The tests serve as a COVID-19 diagnostic testing and Respiratory Pathogen Profile (RPP) kits.

CPT Medical is also developing home testing kits to be ordered by physicians for their patients to help mitigate transmission of the virus between patients and healthcare providers. These in-home testing kits will not be available to the general public directly, but will be accessible by physicians for their patients.

The World Health Organization has reportedly urged all countries to test every suspected case.